The Clinical Trial Vanguard: C2N Diagnostics partners with Precivity™ Alzheimer’s Blood Test Expansion in Japan

May 2

Written by Joni Henderson

St. Louis Post Dispatch: A St. Louis firm races to diagnose Alzheimer’s faster

Fierce Biotech: Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests